Validity of the CAPRA Score to Predict Biochemical Recurrence-Free Survival After Radical Prostatectomy. Results From a European Multicenter Survey of 1,296 Patients-Reference-Cited by-同舟云学术

Validity of the CAPRA Score to Predict Biochemical Recurrence-Free Survival After Radical Prostatectomy. Results From a European Multicenter Survey of 1,296 Patients

Published:2007-11 Issue:5 Volume:178 Page:1957-1962
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

May Matthias¹,Knoll Nina²,Siegsmund Michael³,Fahlenkamp Dirk⁴,Vogler Horst⁵,Hoschke Bernd¹,Gralla Oliver⁶

Affiliation:

1. Department of Urology, Carl-Thiem Hospital, Cottbus, Germany

2. Institute of Medical Psychology, Charité – Universitätsmedizin Berlin, Germany

3. Department of Urology, Vivantes-Clinic Am Urban, Berlin, Germany

4. Department of Urology, Bethanien-Clinic, Chemnitz, Germany

5. Department of Urology, Vivantes-Clinic im Friedrichshain, Berlin, Germany

6. Departments of Andrology and Urology, University Hospital, Cologne, Germany

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference12 articles.

1. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy);Tewari;Urology,2006

2. Survival associated with treatment vs observation of localized prostate cancer in elderly men;Wong;JAMA,2006

3. Nomograms for prostate cancer;Stephenson;BJU Int,2006

4. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer;Kattan;J Natl Cancer Inst,1998

5. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D’Amico;JAMA,1998

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EAU RISK GROUPS APPLIED ON PATIENTS TREATED WITH RADICAL PROSTATECTOMY - ANALYSIS OF PATHOLOGY SPECIMENS AND PATIENT SURVIVAL;Journal of IMAB - Annual Proceeding (Scientific Papers);2024-02-27

2. Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools;Clinical Genitourinary Cancer;2023-08

3. Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1;Cancers;2023-06-16

4. Grossing and reporting of radical prostatectomy specimens: An evidence-based approach;Indian Journal of Cancer;2023

5. Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate Cancer;Frontiers in Oncology;2021-05-28